Association of Daily Glucocorticoid Dose With Worse Patient-Reported Outcomes in Systemic Lupus Erythematosus: Data From the Almenara Lupus Cohort
The daily GC dose is associated with worse PROs in patients with SLE in LLDAS, even after adjusting for possible confounders.
Authors
- Risto Perich-Campos
- Anubhav Singh (ORCID: https://orcid.org/0000-0001-9179-9628)
- Zoila Rodríguez‐Bellido
- Victor R. Pimentel-Quiroz
- Cesar Pastor-Asurza
- Graciela S. Alarcón
- Rocío V. Gamboa-Cárdenas
Institutions
- Universidad Científica del Sur (PE)
- University of Alabama at Birmingham (US)
- Baptist Hospital (US)
- Hospital Base Guillermo Almenara Irigoyen (PE)
Publication Details
- Journal
- The Journal of Rheumatology
- Published
- 2026-02-01
- DOI
- https://doi.org/10.3899/jrheum.2025-0394
- Primary Topic
- Systemic Lupus Erythematosus Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00